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Background: High altitude (HA) exposure can lead to changes in resting heart rate
variability (HRV), which may be linked to acute mountain sickness (AMS) development.
Compared with traditional HRV measures, non-linear HRV appears to offer incremental
and prognostic data, yet its utility and relationship to AMS have been barely examined
at HA. This study sought to examine this relationship at terrestrial HA.
Methods: Sixteen healthy British military servicemen were studied at baseline (800 m,
first night) and over eight consecutive nights, at a sleeping altitude of up to 3600 m.
A disposable cardiac patch monitor was used, to record the nocturnal cardiac inter-
beat interval data, over 1 h (0200–0300 h), for offline HRV assessment. Non-linear HRV
measures included Sample entropy (SampEn), the short (α1, 4–12 beats) and long-term
(α2, 13–64 beats) detrend fluctuation analysis slope and the correlation dimension (D2).
The maximal rating of perceived exertion (RPE), during daily exercise, was assessed
using the Borg 6–20 RPE scale.
Results: All subjects completed the HA exposure. The average age of included subjects
was 31.4 ± 8.1 years. HA led to a significant fall in SpO2 and increase in heart rate, LLS
and RPE. There were no significant changes in the ECG-derived respiratory rate or in
any of the time domain measures of HRV during sleep. The only notable changes in
frequency domain measures of HRV were an increase in LF and fall in HFnu power at
the highest altitude. Conversely, SampEn, SD1/SD2 and D2 all fell, whereas α1 and α2
increased (p < 0.05). RPE inversely correlated with SD1/SD2 (r = −0.31; p = 0.002),
SampEn (r = −0.22; p = 0.03), HFnu (r = −0.27; p = 0.007) and positively correlated
with LF (r = 0.24; p = 0.02), LF/HF (r = 0.24; p = 0.02), α1 (r = 0.32; p = 0.002) and α2
(r = 0.21; p = 0.04). AMS occurred in 7/16 subjects (43.8%) and was very mild in 85.7%
of cases. HRV failed to predict AMS.
Conclusion: Non-linear HRV is more sensitive to the effects of HA than time and
frequency domain indices. HA leads to a compensatory decrease in nocturnal HRV
and complexity, which is influenced by the RPE measured at the end of the previous
day. HRV failed to predict AMS development.
Keywords: heart rate variability, high altitude, cardiac patch, acute mountain sickness, non-linear, rating of
perceived exertion
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INTRODUCTION
High altitude (HA) exposure leads to a number of well recognized
physiological responses under hypobaric hypoxia (West, 2006).
These include increases in resting minute ventilation and
pulmonary artery systolic pressure (West, 2006). Resting cardiac
output increases which is principally driven by a rise in resting
heart with little change in stroke volume (Boos et al., 2016b).
The influence of HA on the changes in cardiac inter-beat
intervals (IBI), known as heart rate variability (HRV), has been
an area of significant recent research interest (Huang et al., 2010;
Karinen et al., 2012; Boos et al., 2016a, 2017b; Mellor et al., 2017).
This attention relates, in part, to the fact many of the factors that
are known to affect HRV (e.g., fatigue, stress, insomnia, hypoxia,
and cold) are predominant at HA (West, 2006; Kemp et al., 2012;
Kiviniemi et al., 2014). The improved portability and reduced cost
of HRV recording equipment has helped to create new research
opportunities at HA, that were previously untenable. Cardiac
patch monitoring represents a significant advance in this regard.
Patch monitors can non-invasively and accurately measure the
cardiac IBIs, whilst negating the need for intrusive chest straps
or electrocardiogram cables that are prone to interference and
detachment. Despite these advantages, their utility to assess HRV
at HA has not been examined.
There is evidence to suggest that HA exposure is associated
with significant changes in HRV compared with sea-level/low
altitude (Huang et al., 2010; Karinen et al., 2012; Boos et al.,
2016a, 2017b; Mellor et al., 2017). However, the majority of the
published data relate to short-term HRV recordings (1–5 min)
obtained conducted in hypoxic chambers during ‘simulated’
rather than genuine terrestrial HA (Vigo et al., 2010; Prabhakaran
and Tripathi, 2011; Mairer et al., 2013; Zhang et al., 2014). The
hypoxic period examined has been generally brief (minutes to
<8 h) with a tendency to assess at a single HA (Saito et al., 2005;
Sutherland et al., 2017) leading to an under appreciation of the
influence of acclimatization on HRV. Furthermore, despite the
known influence of sleep on autonomic function, there has been
a distinct lack of research into nocturnal HRV at HA (Chouchou
and Desseilles, 2014; Taralov et al., 2015).
Despite these research limitations there is some, albeit limited
data, supporting a potential link between changes in HRV at
HA and acute mountain sickness (AMS) development (Huang
et al., 2010; Karinen et al., 2012; Boos et al., 2017b; Sutherland
et al., 2017). However, there are marked inconsistencies in the
published results. This may relate to the heterogeneity, in the
methods used to assess HRV, the HA environment (terrestrial
versus simulated; severity and duration of hypoxia), exercise
intensity and in the populations studied (Mellor et al., 2014; Boos
et al., 2016a).
There is an increasing appreciation that traditional time
and frequency domain measures of HRV that have dominated
the literature, provide an incomplete representation of the
complexity of IBI variability and autonomic balance (Sassi et al.,
2015). Consequently, a number of non-linear measures of HRV
have emerged that provide incremental and prognostic data (Sassi
et al., 2015). To date these parameters have barely been examined
at terrestrial HA (Di Rienzo et al., 2010).
In this study we aimed to assess, for the first time, the use
of a cardiac patch monitor to assess both linear and non-linear
measures of HRV at terrestrial HA.
MATERIALS AND METHODS
Subjects
Sixteen healthy British military servicemen, undergoing military
training in the Bernese Alps, were studied (the ascent profile
is shown in Figure 1). All participants arrived by road to their
800 m basecamp, where they spent their first night. Thereafter,
their second and third nights were at 2840 m (accessed by road
to 1200 m then on foot over 4 h carrying a weight of 15 kg).
During their days at 2840 m they underwent training serials on
a nearby glacier. Their fourth night was spent back at the 800 m
basecamp. Following this they were split into two equal groups
of eight participants with one group of eight spending their fifth
and sixth nights in huts at 3658 m and the other at 2543 m. Those
based at 3658 m underwent a daytime HA acclimatization climb
to 4100 m, whereas those at 2543 m climbed to 3583 m. Both
groups descended to their huts to sleep. All subjects spent their
seventh and eighth nights back at basecamp (800 m) where they
stayed till the end of the data collection (day 9). The subjects slept
in sleeping bags in tents at 800 m and in beds with sleeping bags
in huts at the higher altitudes.
Physiological and Physical Assessments
Assessment of SpO2 and HA related symptoms were measured,
during seated rest, in the early morning at each altitude.
HA-related symptoms were recorded using the Lake Louise
Scoring (LLS) system (Roach et al., 1993). This allocates a
symptom score ranging from 0 (none) to 3 (severe) to the
following five symptoms: difficulty sleeping, gastrointestinal
symptoms, fatigue/weakness, dizziness/lightheadedness, and
headache. A LLS of ≥3 in the presence of headache and a recent
altitude gain was used to define AMS as previously described
(Roach et al., 1993; Boos et al., 2016a). Mild AMS was defined
FIGURE 1 | Ascent Profile of the subjects. Heart rate variability (HRV)
recordings were taken at 0200–0300 each night.
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as the presence of AMS and a LLS of 3–4 and severe when the
LLS was ≥5 (Roach et al., 1993; Boos et al., 2016a). The rating
of perceived exertion (RPE) during the day (sessional RPE) was
assessed at the end of each day, using a 6–20 scale as previously
described (Borg, 1970; Foster et al., 2001; Mellor et al., 2014).
Assessment of Heart Rate Variability
Continuous cardiac IBIs for each subject were recorded using
a lightweight (6 grams) disposable 120 × 42 ×5 mm adhesive
patch monitor (Health strip, LumiraDx; Quinlan et al., 2015) that
was provided for this study free of charge. It was made available
for investigational use in this study and is currently awaiting
a CE mark. The Health strip contains two internal hydrogel
electrodes (Figure 2). The patches were placed following simple
skin preparation (shaving and an alcohol wipe). The subjects
wore their patches continuously throughout the study period
and the patches were replaced as necessary. The patches were
placed over the second to the fourth intercostal space at angle
of 45 degrees (toward the cardiac apex). The data was stored
on the patch monitor prior to daily data Bluetooth transfer to
an iPhone 6s smartphone. This coded cardiac data were then
securely transferred using Wi-Fi for later HRV analysis.
Heart rate variability was assessed over a 1 h nocturnal
cardiac recording period from 0200 to 0300 h during sleep
each of the eight consecutive nights. The Health strip also
records physical activity and body position (upright, supine on
back, lying on side) by a movement sensor, which supports the
confirmation of genuine sleep, which was documented as an
activity percentage/minute. A 36 s full disclosure single lead ECG
(Sampling frequency 250 Hz) was additionally recorded over the
middle 36 s (0230 h) of each 1 h.
Heart rate variability analysis of the exported nocturnal 1 h IBI
data from the Health strip were performed on desktop computer
using dedicated HRV software (Kubios R© Premium ver. 3.0.2)1
as previously described (Tarvainen et al., 2014). Prior to HRV
computation all IBI data were visually inspected for correctness
and then underwent automatic artifact correction. The default
1http://www.kubios.com/
FIGURE 2 | Illustration of the Health strip Cardiac Patch Monitor.
sample length was set to 3600 s (1 h) and over the number of
IBIs generated in this time frame.
Time and frequency domain measures of HRV were calculated
according to the HRV Task Force Guidelines (Task Force of the
European Society of Cardiology and the North American Society
of Pacing Electrophysiology, 1996) The following established
time domain measures of HRV were assed: SDNN (standard
deviation of the NN intervals), RMSSD (root mean square of
successive differences), pNN50% (the number of NN intervals
that differ by >50 ms divided by the total number of NN
intervals). Prior to calculation of the spectral HRV parameters,
the Kubios default smoothness priors detrending was employed
(Lambda, λ value = 500) as previously described (Tarvainen
et al., 2014; Ga˛sior et al., 2016). The IBIs were transformed to
evenly sampled time series with 4-Hz interpolation resampling
rate. The detrended and interpolated IBIs were used for the
frequency-domain HRV analysis. HRV spectra were calculated by
using the fast Fourier transform (FFT) with Welch’s periodogram
method (50% overlap window and 300 s window width) as
previously described (Ga˛sior et al., 2016). We reported the low-
frequency (LF) (0.04–0.15 Hz) and HF (high-frequency) power
(0.15–0.40 Hz) and the LF/HF ratio as previously described (Task
Force of the European Society of Cardiology and the North
American Society of Pacing Electrophysiology, 1996). Due to
skewed distributions, LF and HF power were transformed by
natural logarithms (ln). In order obtain greater insight into the
relative HF power it was also reported in normalized units HF
(HFnu) which was calculated as HF/(LF + HF) (Task Force of
the European Society of Cardiology and the North American
Society of Pacing Electrophysiology, 1996). Non-linear HRV
assessment were examined as previously described (Sassi et al.,
2015) using Poincaré plots and the derived ratio of the standard
deviation (SD) of long term (SD2) to short term (SD1) variability
known as SD1/SD2 ratio, Sample entropy (SampEn), the short
(α1, 4–12 beats) and long term detrend fluctuation analysis
(DFA) slopes (α2, 13–64 beats) and the correlation dimension
(D2) (Sassi et al., 2015). The Poincaré plot is a scatterplot
in which current IBIs are plotted as a function of previous
interval. SD1 represents the SD of short-term HRV and SD2
(or major axis) the continuous longer term IBIs (Task Force of the
European Society of Cardiology and the North American Society
of Pacing Electrophysiology, 1996). The SD1/SD2 ratio measures
the unpredictability of the RR time series (Shaffer and Ginsberg,
2017). SampEn is a measure of the regularity and fluctuation of
a time series with lower values representing less complexity and
greater self-similarity in a time series (Richman and Moorman,
2000). DFA detects the simple correlations between successive
RRIs over differing time scales with α1 reflecting the slope over
shorter fluctuations and α2 over longer time periods (Shaffer
and Ginsberg, 2017). D2 is an estimation of the number of
independent variables necessary to describe a systems behavior
with a higher value representing greater complexity (Sassi et al.,
2015).
Calculation of the respiratory rate was obtained by ECG-
derived respiration (EDR) software within the HRV analysis
package as previously described, using the 36 s Health strip ECG
recording (Babaeizadeh et al., 2011).
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Statistical Analysis and Sample Size
Calculation
Data were analyzed using GraphPad InStat version 3.05 and
with all graphical figures presented using GraphPad Version
3.10 (GraphPad Software, San Diego, CA, United States)2. Data
inspection and the Kolmogorov–Smirnov test was undertaken to
assess normality of all continuous data. Results are presented as
mean± SD for all data. Comparison of continuous data between
altitudes was performed using a one-way ANOVA with Tukey
posttest and with Kruskal–Wallis test with Dunn-Posttest for
parametric and non-parametric data, respectively. Correlations
of continuous data were assessed using the Pearson and
Spearman rank correlation coefficients (r) and 95% confidence
interval, for parametric and non-parametric data, respectively.
A two-sided p-value of < 0.05 was considered as significant for
all analyses.
In a previous, yet recent study, we had observed a significant
11% (7.9 ms) change in the RMSSD-derived HRV score between
baseline sea level and 3619 m in a cohort of 12 persons (Boos et al.,
2016a). Zhang et al. (2015) recently observed a significant fall
in SampEn in eight healthy male subjects, following short term
exposure to simulated HA from sea level to 3600 m. Based on this
later data, we calculated that a sample size of at least 14 subjects
would have sufficient power to examine for differences in RMSSD
and a ≥80% to detect a difference in mean SampEn of ≥0.18
at a significance level (alpha) of 0.05 (two-tailed) (GraphPad
Statmate).
Ethics Statement
All participation was entirely voluntary and all subjects
underwent detailed written informed consent >24 h after being
sent a participant information sheet for the study. This study
was approved by the Ministry of Defence Research and Medical
Ethics Committee (MODREC) and was conducted according to
the standards of the Declaration of Helsinki.
RESULTS
The average age of included subjects was 31.4 ± 8.1 years. They
had mean height of 179.8± 5.0 cm, weight of 84.6± 11.0 kg and
2www.graphpad.com
body mass index of 26.1± 2.7 kg/m2. All of the participants were
non-smokers and were not on any regular medication.
Compared with baseline, ascent to HA ≥2543 m was
associated with a significant fall in SpO2, higher RPE scores, and
an increase in average heart rate, LLS and in the average sleep
score component of the LLS (Table 1).
The mean number of patches used per subject over the study
was 1.94 ± 0.25 (range 1–2), with all, but one subject, requiring
two patches. The recorded cardiac IBI data were good quality
with an artifact rate of < 3% at all altitudes studied, but was
significantly higher at higher altitude at ≥2543 m versus baseline
800 m (Table 1). There were no significant overall changes in any
of the time domain measures of HRV (Table 2). The only notable
change in frequency domain measures of HRV was an increase
in LF power and fall in HFnu at the highest altitude (Table 2).
There were significant changes in all of the non-linear measures
of HRV at HA: SampEn, SD1/SD2 and D2 fell, whereas α1 and α2
increased (P < 0.05) (Table 3).
Rating of perceived exertion inversely correlated with HFnu,
SD1/SD2 and SampEn and positively correlated with LF, LF/HF,
α1, and α2, but not the other HRV indices (Table 4). Among
the non-linear indices only SD1/SD2 inversely correlated with
α1 (r = −0.87; −0.91 to −0.81: p < 0.0001), α2 (r = 0.28;
−0.44 to −0.10: p = 0.003). SampEn inversely correlated with α2
(r = −0.27; −0.44 to −0.1: p = 0.003) and D2 inversely with α2
(r =−0.35;−0.51 to−0.17: p = 0.0001).
Seven out of the sixteen subjects (43.8%) suffered with AMS.
These were all self-limiting and in all but one were mild episodes
(LLS score 3–4). HRV scores failed to predict AMS.
DISCUSSION
This is the first study to assess the utility of a cardiac patch
monitor to assess non-linear measures of HRV at HA. We found
that non-linear HRV was more sensitive to the effects of HA than
traditional time and frequency domain HRV measurements. HA
led to a significant fall in SD1/SD2, D2, and SampEn and an
increase in α1 and α2. We observed a significant relationship
between nocturnal HRV and RPE measured at the end of the
previous day. HRV measures failed to predict the development
of AMS.
We chose to examine the effects of HA on several non-
linear HRV parameters, given the paucity of data at HA and
TABLE 1 | Changes in physiological measurements, Lake Louise scores and rating of perceived exertion (RPE).
Altitude 800 m (1) 2840 m 800 m (2) 2543–3658 m 800 m (3) P-value
SpO2, % 96.8 ± 1.2 92.2 ± 2.4 96.1 ± 2.0 90.0 ± 3.3 95.9 ± 3.0 <0.0001acef
Mean heart rate, minute−1 53.2 ± 7.3 68.8 ± 14.9 68.9 ± 17.9 65.0 ± 13.4 60.8 ± 9.3 0.001abc
ECG-derived Respiratory rate 16.7 ± 3.9 17.3 ± 2.0 16.8 ± 3.6 16.9 ± 3.4 16.9 ± 4.6 0.90
Lake Louise total scores 0.2 ± 0.6 1.0 ± 1.1 0.5 ± 1.2 1.4 ± 1.5 0.4 ± 0.70 <0.0001acf
Lake Louise sleep scores 0.0 ± 0.2 0.6 ± 0.8 0.0 0.3 ± 0.7 0.1 ± 0.5 <0.0001ae
RPE score 10.8 ± 2.8 11.40 ± 2.6 10.2 ± 3.5 12.4 ± 2.5 10.4 ± 1.9 0.02cef
SpO2, capillary oxygen saturation; RPE, rating of perceived exertion (Borg 14–20 score). Significant post-test differences vs. baseline 800 m (1): a 2840 m; b 800 m (2);
c 2543–3658 m; d 800 m (3); e 800 m (2) vs. 2840 m; f 800 m (2) vs. 2543–3658 m.
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TABLE 2 | Comparative time and frequency domain heart rate variability (HRV) parameters at high altitude (HA).
Altitude 800 m (1) 2840 m 800 m (2) 2543–3658 m 800 m (3) P-value
Artifact % 1.1 ± 1.1 2.4 ± 1.8 1.6 ± 1.0 2.6 ± 1.7 1.1 ± 0.7 0.001acg
LnSDNN 4.2 ± 0.4 4.3 ± 0.6 4.2 ± 0.7 4.5 ± 0.40 4.0 ± 0.8 0.09
LnRMSSD 4.4 ± 0.5 4.2 ± 0.8 4.2 ± 0.8 4.40 ± 0.60 4.0 ± 0.9 0.45
pNNI% 39.4 ± 18.9 28.9 ± 23.3 21.8 ± 25.1 37.7 ± 18.4 25.4 ± 22.7 0.35
Triangular index 15.1 ± 3.70 15.1 ± 8.70 16.6 ± 13.3 19.6 ± 11.2 14.2 ± 9.1 0.09
LnLF 7.6 ± 0.6 7.6 ± 1.0 7.5 ± 1.3 8.4 ± 0.8 7.0 ± 1.5 0.004eg
LnHF 7.3 ± 1.0 7.1 ± 1.6 7.2 ± 1.6 7.5 ± 1.2 6.8 ± 1.6 0.59
HFnu,% 40.5 ± 15.1 36.4 ± 17.4 43.3 ± 16.3 31.9 ± 16.0 43.3 ± 15.7 0.04fg
LF/HF ratio 1.7 ± 1.0 2.8 ± 2.6 1.7 ± 1.2 2.9 ± 2.0 1.6 ± 01.1 0.09
SDNN, standard deviation of normal-to-normal; RMSSD, root mean square of successive differences; pNNI%, Percentage of successive RRs >50 ms; LF, Low frequency;
HF, high frequency; Significant post-test differences: vs. baseline 800 m (1), a 2840 m, b 800 m (2), c 2543–3658 m, d 800 m (3); e 800 m (2) vs. 2840 m; f 800 m (2) vs.
2543–3658 m; g 800 m (3) vs. 2543–3658 m.
TABLE 3 | Effect of HA on Non-linear measures of HRV.
Altitude 800 m (1) 2840 m 800 m (2) 2543–3658 m 800 m (3) P-value
SD1/SD2 0.6 ± 0.1 0.5 ± 0.2 0.6 ± 0.2 0.5 ± 0.2 0.6 ± 0.2 0.02cf
Sample entropy 1.6 ± 0.2 1.4 ± 0.3 1.6 ± 0.3 1.4 ± 0.2 1.7 ± 0.2 0.0004ace
DFA α1 1.0 ± 0.2 1.2 ± 0.3 1.0 ± 0.3 1.1 ± 0.2 0.9 ± 0.2 0.006acef
DFA α2 0.4 ± 0.10 0.5 ± 0.10 0.4 ± 0.1 0.4 ± 0.1 0.4 ± 0.2 0.03ac
D2 3.4 ± 1.4 2.1 ± 1.3 2.3 ± 1.5 2.9 ± 1.3 2.1 ± 1.6 0.03ad
SD, standard deviation; DFA, detrend fluctuation analysis; D2, Correlation Dimension. Significant post-test differences vs. baseline 800 m (1): a 2840 m; b 800 m (2);
c 2543–3658 m; d 800 m (3); e 800 m (2) vs. 2840 m; f 800 m (2) vs. 2543–3658 m.
TABLE 4 | Correlation between RPE and HRV measures
HRV
parameter
Correlation
coefficient
95% Confidence
interval
P-value
HFnu −0.27 −0.45 to −0.07 0.007
LF 0.24 0.04 to 0.44 0.02
LF/HF 0.24 0.04 to 0.42 0.02
SD1/SD2 −0.31 −0.49 to −0.10 0.002
Sample entropy −0.22 −0.40 to 0.02 0.03
α1 0.32 0.11 to 0.49 0.002
α2 0.21 0.1 to 0.40 0.04
LF, Low frequency; HF, high frequency; SD, standard deviation.
their potential advantages over established time and frequency
domain HRV parameters. Their advantages include its lower
sensitivity to the presence of cardiac ectopy, artifacts and to the
recording period, which is of greater relevance at HA (Voss et al.,
2008). The non-linear HRV parameters examined in this study
were the SD1/SD2 ratio obtained from Poincaré plots, SampEn,
α1, and α2 and D2. We found that SampEn was significantly
lower at HA at both 2840 and 2543–3658 m compared with
baseline. Conversely the α1 and α2 increased from baseline
to 2480 and 2543–3658 m, with a return to near baseline
levels at 800 m. D2 and SD1/SD2 values were also significantly
lower at HA versus 800 m. These findings suggest that HA to
≥2543 m leads to a compensatory change in autonomic balance
with increased regularity (lower HRV) and lower complexity
and chaos in the cardiac IBI signal (Shaffer and Ginsberg,
2017).
Our data is largely consisted with that obtained from several
recent acute hypoxia studies. In their study of eight healthy men
exposed to acute normobaric hypoxia (equivalent to 3600 m)
for 10 min, Zhang et al. (2015) also reported a fall in SampEn,
measured over a 1 min recording period. Their observed values
of α1, which was also studied, were similar to our current study
and very close to 1.0, but did not change significantly. In another
study of ten healthy men, supine HRV was measured during
intermittent periods of acute normobaric hypoxia (simulated HA;
FIO2 down to 9.8%) (Giles et al., 2016). Again, a significant
fall in SampEn was observed, but on this occasion it was
associated with a significant increase in α1, which is consistent
with our data. Due to the brevity of the HRV recording period
in their study, α2 and other non-linear HRV measures were not
examined.
In this study we assessed HRV during sleep at HA. Our interest
in specifically examining this period was stimulated by a number
of factors. Firstly, it has been well shown that sleep and its stages
are associated with marked variability in autonomic modulation
of cardiac activity that is typified higher parasympathetic
tone during normal non-rapid eye movement sleep (REMS)
and a shift toward sympathetic predominance during normal
REMS (Tobaldini et al., 2013; Chouchou and Desseilles, 2014).
Secondly, ventilation, which can have a significant influence
on HRV, is affected by HA (Task Force of the European
Society of Cardiology and the North American Society of Pacing
Electrophysiology, 1996). Alterations in breathing patterns and
even periodic breathing (PB) are a well-established phenomenon
at HA (Burgess and Ainslie, 2016). PB represents an abnormal
ventilatory pattern in which apneas and hypopneas alternate
Frontiers in Physiology | www.frontiersin.org 5 April 2018 | Volume 9 | Article 390
fphys-09-00390 April 12, 2018 Time: 16:13 # 6
Boos et al. High Altitude Heart Rate Variability
with periods of hyperventilation (Burgess and Ainslie, 2016).
The worsening hypobaric hypoxia at HA leads to compensatory
hyperventilation until a point when the arterial PCO2 (PaCO2)
falls below the threshold required to stimulate breathing leading
to either hypopnea or even apnea, followed by the restoration
of hyperventilation as the hypoxia worsens and the paCO2
resets (Burgess and Ainslie, 2016). This phenomenon is subject
to marked individual variability, but is generally observed at
>2000 m (Burgess and Ainslie, 2016). Unfortunately, we were not
able to measure ventilation throughout the 1 h recording period,
but did quantify the ECG derived respiratory rate during part of
the HRV recording period. It is highly likely that there were cases
of PB and the observed swings in the IBI raise this suspicion.
Nevertheless, wary of the confounding effect of sleep stage and
potentially PB on HRV we selected a 1-h HRV recording period
in preference to a traditional 5-min recording to minimize this
potential bias (Task Force of the European Society of Cardiology
and the North American Society of Pacing Electrophysiology,
1996).
By using an adhesive cardiac patch monitor (and avoiding
ECG cables and minimizing movement artifact) we were able
to overcome the obvious challenges of accurately, yet non-
intrusively measuring HRV during sleep at HA. However, poor
sleep was still a significant contributor to the total LLS at each
altitude in our study. The sleep score component of the LLS was
significantly higher at 2840 m compared with 800 m, indicating
perceptually worse sleep at higher altitude (Table 1). Whilst
reduced HRV with insomnia is a widely accepted concept, it has
not been well supported by empirical evidence (Dodds et al.,
2016). Reduced sleep quality and insomnia are common at HA,
but its effect on HRV has not been examined. Unfortunately, we
were unable to assess the sleep stages during the HRV recording
or the total sleep time prior to HRV recording. However, the
subjects generally went to sleep before 2300 h each night and the
activity sensor on the Health strip confirmed that subjects were
supine and largely inactive during the HRV defined nocturnal
HRV recording period.
The significant, yet modest, relationship between end of day
RPE and nocturnal HRV is a novel finding at HA. Our data
support the temporal effects of heavy exercise and exhaustion on
HRV (Taralov et al., 2015). Higher RPE appeared to be associated
with lower nocturnal HRV and greater LF/HF dominance.
This study has a number of additional strengths and
limitations that should be acknowledged. The fact that we were
we studied three separate terrestrial altitudes, yet included a far
larger sample size than the majority of published acute hypoxic
chamber studies are obvious strengths. The wide breadth of HRV
parameters and physiological measurement examined, allowed
for a comprehensive assessment of HRV at HA. Baseline HRV
studies were performed at 800 m rather than sea level due to
practical issues, which could have reduced the effect size. It was
not possible to control the subjects sleeping position (e.g., prone
or on side) and their sleeping conditions varied with altitude
which may be potential confounders (Ryan et al., 2003). The
altitude studied was modest and the majority of AMS cases
were mild, hence we cannot be certain whether our findings
would be reproducible at higher altitudes and with worsening
AMS severity. The duration and intensity of exercise varied with
altitude, which whilst being a relevant confounder, reflects the
reality of a real world terrestrial HA venture. We were only
able to absolutely confirm the presence of normal sinus rhythm
at the time of the 36 sec ECG capture. Whilst this does not
fully exclude the possibility of arrhythmias at other time points
visualization of the IBI data coupled with the altitude and healthy
population studied would strongly suggest against the presence of
an undetected significant cardiac arrhythmia (Boos et al., 2017a).
CONCLUSION
This study demonstrated that moderate terrestrial HA exposure
leads to significant changes in resting nocturnal non-linear HRV
that is typified by increased regularity and lower complexity
and chaos of the cardiac inter-beat signal. These changes are
influenced by the intensity of exercise over the previous day.
Nocturnal HRV was not predictive of AMS.
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